Lackritz Eve M, Ng Lee-Ching, Marques Ernesto T A, Rabe Ingrid B, Bourne Nigel, Staples J Erin, Méndez-Rico Jairo A, Harris Eva, Brault Aaron C, Ko Albert I, Beasley David W C, Leighton Tabitha, Wilder-Smith Annelies, Ostrowsky Julia T, Mehr Angela J, Ulrich Angela K, Velayudhan Raman, Golding Josephine P, Fay Petra C, Cehovin Ana, Moua Nicolina M, Moore Kristine A, Osterholm Michael T, Barrett Alan D T
Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA.
National Environment Agency, Environmental Health Institute, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Lancet Infect Dis. 2025 Jul;25(7):e390-e401. doi: 10.1016/S1473-3099(24)00794-1. Epub 2025 Feb 27.
The 2015-16 Zika virus epidemic emerged in the Americas and rapidly spread throughout the region and beyond, showing the epidemic potential of this mosquito-borne Orthoflavivirus and its capacity to cause severe congenital malformations and neurological sequelae. WHO declared the Zika virus epidemic a public health emergency of international concern in 2016. Despite this declaration, there are no licensed Zika virus vaccines, therapeutics, or diagnostic tests appropriate for routine antenatal screening. To address this absence of essential tools to detect and mitigate the threat of future Zika virus outbreaks, a group of global experts developed a priority agenda for Zika virus research and development. This Series paper summarises crucial challenges and knowledge gaps and outlines a comprehensive strategy to advance research, surveillance, global capacity, policy, and investment for Zika virus preparedness and response.
2015 - 16年寨卡病毒疫情在美洲出现,并迅速蔓延至该地区及其他地区,显示出这种蚊媒黄病毒属病毒的流行潜力及其导致严重先天性畸形和神经后遗症的能力。2016年,世界卫生组织宣布寨卡病毒疫情为国际关注的突发公共卫生事件。尽管有这一宣布,但目前尚无适用于常规产前筛查的获批寨卡病毒疫苗、治疗方法或诊断检测手段。为应对检测和减轻未来寨卡病毒爆发威胁的基本工具缺失这一问题,一群全球专家制定了寨卡病毒研发优先议程。本系列文章总结了关键挑战和知识空白,并概述了一项全面战略,以推进寨卡病毒防范和应对方面的研究、监测、全球能力、政策及投资。